Margaret A. Horn, Chief Operating Officer at Revolution Medicines, Inc. (RVMD), sold 10,000 shares at $144.28 ($1.5M) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Scheduled sale ($1.5M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $144.28 | 1,315 | $190K | 12.8% |
| 2 | $145.15 | 885 | $128K | 8.7% |
| 3 | $146.04 | 700 | $102K | 6.9% |
| 4 | $147.27 | 500 | $74K | 5.0% |
| 5 | $148.72 | 1,800 | $268K | 18.1% |
| 6 | $149.64 | 4,600 |
| $688K |
| 46.5% |
| 7 | $150.17 | 200 | $30K | 2.0% |
| Total | $148.01 avg | 10,000 | $1.5M | 100% |
| Filing → |
| RVMD | SELL | 2026-03-19 | $912K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $14.9M | — | Filing → |
| RVMD | SELL | 2025-12-18 | $745K | — | Filing → |